Difference between revisions of "Dermagraft-TC"
Jump to navigation
Jump to search
m (decapitalize category names) |
m (remove <coauthors> parameter) |
||
| Line 1: | Line 1: | ||
[[Image:Dermagraft.png|right|thumb|]] | [[Image:Dermagraft.png|right|thumb|]] | ||
| − | Dermagraft-TC which is an artifical skin created from harvested foreskins from infant circumcision.<ref name='Advanced Biohealing, 2010'>{{REFweb | + | '''Dermagraft-TC''' which is an artifical skin created from harvested foreskins from infant circumcision.<ref name='Advanced Biohealing, 2010'>{{REFweb |
|quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue. | |quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue. | ||
|url=http://www.dermagraft.com/about/overview/ | |url=http://www.dermagraft.com/about/overview/ | ||
| Line 23: | Line 23: | ||
|last= | |last= | ||
|first= | |first= | ||
| − | |||
|url=http://www.highbeam.com/doc/1G1-47248437.html | |url=http://www.highbeam.com/doc/1G1-47248437.html | ||
|title=Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA | |title=Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA | ||
Revision as of 21:39, 19 October 2019
Dermagraft-TC which is an artifical skin created from harvested foreskins from infant circumcision.[1] It is made and sold by Advanced Tissue Sciences (ATS), which is a corporation based in La Jolla, CA. Dermagraft-TC is FDA approved,[2][3] and it sells for about $3,000 per square foot; one foreskin contains enough genetic material to grow 250,000 square feet of skin.[4]
References
- ↑
Dermagraft-TC: Overview
, Advanced Biohealing, Inc.. Retrieved 6 March 2011.
Quote:Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.
- ↑
Dermagraft-TC
, MediLexicon. Retrieved 6 March 2011.
Quote:...fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.
- ↑
(28 March 2007)."Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA", Transplant News. Retrieved 6 March 2011.
Quote:...the Food and Drug Administration has approved Dermagraft-TC for marketing, making it the first human fibroblast-derived temporary skin substitute to be approved.
- ↑
Daecher, M.. Circumcision. Icon. 1998; 2(2): 70-73.
